SavedAdd your journal

Journals / Fırat Tıp Dergisi / 2018 / Cilt: 23 - Sayı: 0

Nonpharmacologic Treatment in Obesity

Obezitede Nonfarmakolojik Tedavi

Erhan ÖNALAN
EMİR DÖNDER
Pages
68–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In obesity treatment, a 10% decrease in body weight over a six-month period provides important benefits in preventing obesity-induced health problems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity is defined as the increase of fat mass in the body, caused by genetic, environmental, biological, sociocultural and behavioral factors, and it is considered as a chronic and recurrent disease due to the causes of formation, the complications and the diseases it induces.The aim of obesity treat-ment is to decrease obesity related morbidity and mortality risks, to provide adequate and balanced nutrition habits and to improve quality of life.
📊
Key Findings & Data:Obesity is defined as the increase of fat mass in the body, caused by genetic, environmental, biological, sociocultural and behavioral factors, and it is considered as a chronic and recurrent disease due to the causes of formation, the complications and the diseases it induces.The aim of obesity treat-ment is to decrease obesity related morbidity and mortality risks, to provide adequate and balanced nutrition habits and to improve quality of life.
💡
Conclusion & Impact:In obesity treatment, a 10% decrease in body weight over a six-month period provides important benefits in preventing obesity-induced health problems.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity is defined as the increase of fat mass in the body, caused by genetic, environmental, biological, sociocultural and behavioral factors, and it is considered as a chronic and recurrent disease due to the causes of formation, the complications and the diseases it induces.The aim of obesity treat-ment is to decrease obesity related morbidity and mortality risks, to provide adequate and balanced nutrition habits and to improve quality of life. In obesity treatment, a 10% decrease in body weight over a six-month period provides important benefits in preventing obesity-induced health problems.

Özet

Obezite, genetik, çevresel, biyolojik, sosyokültürel ve davranışsal faktörlerin bir araya gelerek ortaya çıkardığı, vücuttaki yağ dokusu kütlesinin artması ile tanımlanan, gerek oluşum nedenleri, gerekse oluşturduğu komplikasyonlar ve zemin hazırladığı hastalıklar nedeniyle kronik ve tekrarlayıcı bir hastalıktır. Obezite tedavisinde amaç, obeziteye ilişkin morbidite ve mortalite risklerini azaltmak, bireye yeterli ve dengeli beslenme alışkanlığı kazandırmak ve yaşam kalitesini yükseltmektir. Obezite tedavisinde vücut ağırlığının 6 aylık dönemde %10 azalması, obezitenin yol açtığı sağlık sorunlarının önlenmesinde önemli yarar sağlamaktadır.

🔖

Cite This Article

ÖNALAN, E., DÖNDER, E. (2018). Nonpharmacologic Treatment in Obesity. Fırat Tıp Dergisi, Cilt: 23 - Sayı: 0, 68–71. https://ajindex.com/articles/223551

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Türkiye Obezite (Şişmanlık) İle Mücadele ve Kontrol Programı (2010-2014), Sağlık Bakanlı-ğı Yayın No: 773, Kuban Matbaacılık Yayıncı-lık, Ankara, 2010. Türkiye’ye Özgü Beslenme Rehberi, T.C. Sağ-lık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, Ankara, 2007.
  2. Çoşkun A, Kesici C, Çelikcan E, Bilici S (Eds): Hastalıklarda Beslenme ve Obezite Bilgi Serisi, Sağlık Bakanlığı Yayın No: 733, Klasmat Mat-baacılık, Ankara, 2008.
  3. Tsigos C, Hainer V, Basdevant A, et al. Mana-gement of obesity in adults: European Clinical Pratice Guidelines, Obesity Facts 2008; 1: 106-16.
  4. Lau DCW, Douketis JD, Morrison KM, et al. 2006 Canadian Clinical Practice Guidelines on the management and prevention of obesity in adults and children. CMAJ 2007; 176: 1-13. Stuart RB. Behavioral control of overeating. Behav Res Ther 1967; 5: 357-65.
  5. Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol 2000; 19: 5-16.
  6. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 di-abetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
  7. Perri MG, Nezu AM, McKelvey WF, et al. Relapse prevention training and problem-solving therapy in the long-term management of obesity. J Consult Clin Psychol 2001; 69: 722-6. Wing RR. Behavioral approaches to the treat-ment of obesity. In: Bray GA, Bouchard C, eds. Handbook of Obesity: Clinical Applications. 2nd ed. New York: Marcel Dekker; 2004.
  8. Bandura A, Simon KM. The role of proximal intentions in self-regulation of refractory beha-vior. Cognit Ther Res 1977; 1: 177-93.
  9. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005; 82 (1 Suppl): 222-5.
  10. McLean N, Griffin S, Toney K, et al. Family involvement in weight control, weight main-tenance and weight-loss interventions: a syste-matic review of randomised trials. Int J Obes Relat Metab Disord 2003; 27: 987-1005.
  11. Avenell A, Broom J, Brown TJ, et al. Systema-tic review of the long-term effects and economic consequences of treatments for obesity and imp-lications for health improvement. Health Tech-nol Assess 2004; 8: 181-2.
  12. Foster GD, Wadden TA, Vogt RA, et al. What is a reasonable weight loss? Patients' expectati-ons and evaluations of obesity treatment outco-mes. J Consult Clin Psychol 1997; 65: 79-85.
  13. Katzel LI, Bleecker ER, Colman EG, et al. Ef-fects of weight loss vs aerobic exercise training on risk factors for coronary disease in health